Key steps for effective breast cancer prevention.

Nature Reviews. Cancer
Kara L BrittKelly-Anne Phillips

Abstract

Despite decades of laboratory, epidemiological and clinical research, breast cancer incidence continues to rise. Breast cancer remains the leading cancer-related cause of disease burden for women, affecting one in 20 globally and as many as one in eight in high-income countries. Reducing breast cancer incidence will likely require both a population-based approach of reducing exposure to modifiable risk factors and a precision-prevention approach of identifying women at increased risk and targeting them for specific interventions, such as risk-reducing medication. We already have the capacity to estimate an individual woman's breast cancer risk using validated risk assessment models, and the accuracy of these models is likely to continue to improve over time, particularly with inclusion of newer risk factors, such as polygenic risk and mammographic density. Evidence-based risk-reducing medications are cheap, widely available and recommended by professional health bodies; however, widespread implementation of these has proven challenging. The barriers to uptake of, and adherence to, current medications will need to be considered as we deepen our understanding of breast cancer initiation and begin developing and testing novel prev...Continue Reading

References

Apr 18, 1990·Journal of the National Cancer Institute·A G Glass, R N Hoover
Jan 1, 1982·Breast Cancer Research and Treatment·J RussoI H Russo
Mar 1, 1994·CA: a Cancer Journal for Clinicians·P Boffetta, D M Parkin
Mar 20, 1996·Journal of the National Cancer Institute·B Rosner, G A Colditz
Aug 1, 1996·The Journal of Clinical Investigation·G van der PluijmS Papapoulos
Sep 27, 1996·International Journal of Cancer. Journal International Du Cancer·S MännistöM Uusitupa
Feb 5, 1997·Journal of the National Cancer Institute·D A BerryE Winer
Mar 7, 1998·American Journal of Human Genetics·G ParmigianiO Aguilar
Jan 14, 1999·The New England Journal of Medicine·L C HartmannR B Jenkins
Nov 5, 1999·Journal of the National Cancer Institute·U VeronesiM B Sporn
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·Y T GaoW Zheng
Apr 27, 2001·American Journal of Epidemiology·E B GoldJ Skurnick
May 3, 2001·Journal of the National Cancer Institute·J F DorganP R Taylor
Nov 22, 2001·JAMA : the Journal of the American Medical Association·K W Singletary, S M Gapstur
Feb 22, 2002·British Journal of Cancer·A C AntoniouD F Easton
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher I LiKathleen E Malone
Jan 31, 2003·British Journal of Cancer·M D AlthuisL A Brinton
Jun 5, 2003·Journal of the National Cancer Institute·Andrea DecensiUmberto Veronesi
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Aug 21, 2003·Breast Cancer Research : BCR·Ruth C Travis, Timothy J Key
Aug 21, 2003·Breast Cancer Research : BCR·Salem AlowamiPeter H Watson
Nov 25, 2003·Menopause : the Journal of the North American Menopause Society·Kerstin RödströmCecilia Bjoürkelund
Apr 2, 2004·Statistics in Medicine·Jonathan TyrerJack Cuzick
May 27, 2004·JAMA : the Journal of the American Medical Association·Mary Beth TerryAlfred I Neugut
Sep 24, 2004·British Journal of Cancer·A C AntoniouD F Easton
Dec 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sharon L BoberNadine M Tung
Mar 2, 2005·International Journal of Epidemiology·Michelle D AlthuisLouise A Brinton
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michelle HarvieThomas A Sellers
Mar 17, 2005·Journal of the National Cancer Institute·Rowan T ChlebowskiRoss Prentice
Jun 2, 2005·Journal of the National Cancer Institute·Sarah F MarshallRonald K Ross

❮ Previous
Next ❯

Citations

Oct 30, 2020·Cancer Prevention Research·Courtney MacdonaldUNKNOWN Kathleen Cuningham Consortium for Research Into Familial Breast Cancer
Jan 22, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Peng-Fei LiuXiao-Tao Zhao
Nov 12, 2020·Geburtshilfe und Frauenheilkunde·Jens HuoberAchim Wöckel
Oct 17, 2020·International Journal of Cancer. Journal International Du Cancer·Yunpeng ZhangSteven Xi Chen
Mar 16, 2021·Frontiers in Oncology·Liting TangYuehua Li
Mar 20, 2021·Advanced Healthcare Materials·Ka-Wai LeeChun-Sing Lee
Apr 11, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ganglei LiJian Shen
Apr 23, 2021·Breast Cancer : Targets and Therapy·Alex A DalyEllen R Copson
Jun 25, 2021·ACS Applied Materials & Interfaces·Tianhui ShiXiaoqing Liu
Aug 7, 2021·International Journal of Breast Cancer·Richard Tagne SimoPhelix Bruno Telefo
Aug 14, 2021·Biochemical and Biophysical Research Communications·Jiawei ZhouJian Huang
Aug 28, 2021·Journal of Mammary Gland Biology and Neoplasia·Gina ReyeHonor J Hugo
Aug 30, 2021·The Breast : Official Journal of the European Society of Mastology·Courtney MacdonaldKelly-Anne Phillips
Sep 21, 2021·Oncology Letters·Xiulan YangJie Zhang
Oct 30, 2021·Biomaterials Science·Tingting GongHong Shan
Nov 23, 2021·Frontiers in Oncology·Guanghui ZhaoHaidong Gao
Dec 18, 2021·Frontiers in Cell and Developmental Biology·Ziwen ZhangXiaojia Wang
Oct 21, 2021·Cancer Prevention Research·Adelaide YoungYi Li
Jan 23, 2022·Journal of Hematology & Oncology·Jianwei QuZhen Cai

❮ Previous
Next ❯

Methods Mentioned

BETA
contraception
GTPase
biopsies
hysterectomy
hormone replacement therapy

Clinical Trials Mentioned

NCT02408770
NCT00078832
NCT03063619
NCT03323658
NCT02781805
NCT00952731

Software Mentioned

iPrevent
BCRAT
Cumulus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Danielle GrahamPatricia A Ganz
Médecine sciences : M/S
André Nkondjock, Parviz Ghadirian
The Surgical Clinics of North America
Lisa A Newman, Victor Vogel
© 2022 Meta ULC. All rights reserved